pubmed-article:12384144 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12384144 | lifeskim:mentions | umls-concept:C0026900 | lld:lifeskim |
pubmed-article:12384144 | lifeskim:mentions | umls-concept:C1326205 | lld:lifeskim |
pubmed-article:12384144 | lifeskim:mentions | umls-concept:C0600432 | lld:lifeskim |
pubmed-article:12384144 | lifeskim:mentions | umls-concept:C0072473 | lld:lifeskim |
pubmed-article:12384144 | lifeskim:mentions | umls-concept:C1512032 | lld:lifeskim |
pubmed-article:12384144 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:12384144 | pubmed:dateCreated | 2002-10-17 | lld:pubmed |
pubmed-article:12384144 | pubmed:abstractText | The aberrant expression of c-myb in leukemic cells suggests that c-myb may play an important role in leukemogenesis. Therefore, disrupting c-myb function might provide a strategy for controlling leukemic cell growth. Use of dominant negative mutants as a strategy for inhibiting oncogene function has attracted considerable attention. The aim of this study was to induce apoptosis in K562 cells by dominant negative c-myb (DN-myb). | lld:pubmed |
pubmed-article:12384144 | pubmed:language | eng | lld:pubmed |
pubmed-article:12384144 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12384144 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12384144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12384144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12384144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12384144 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12384144 | pubmed:month | Oct | lld:pubmed |
pubmed-article:12384144 | pubmed:issn | 0301-472X | lld:pubmed |
pubmed-article:12384144 | pubmed:author | pubmed-author:KimJae... | lld:pubmed |
pubmed-article:12384144 | pubmed:author | pubmed-author:LeeDae YeolDY | lld:pubmed |
pubmed-article:12384144 | pubmed:author | pubmed-author:KimJung SooJS | lld:pubmed |
pubmed-article:12384144 | pubmed:author | pubmed-author:HwangPyoung... | lld:pubmed |
pubmed-article:12384144 | pubmed:author | pubmed-author:YiHo KeunHK | lld:pubmed |
pubmed-article:12384144 | pubmed:author | pubmed-author:NamSang YunSY | lld:pubmed |
pubmed-article:12384144 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12384144 | pubmed:volume | 30 | lld:pubmed |
pubmed-article:12384144 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12384144 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12384144 | pubmed:pagination | 1139-46 | lld:pubmed |
pubmed-article:12384144 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:meshHeading | pubmed-meshheading:12384144... | lld:pubmed |
pubmed-article:12384144 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12384144 | pubmed:articleTitle | Induction of apoptosis in K562 cells by dominant negative c-myb. | lld:pubmed |
pubmed-article:12384144 | pubmed:affiliation | Department of Pediatrics, Chonbuk National University Medical School, Jeonju, South Korea. | lld:pubmed |
pubmed-article:12384144 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12384144 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12384144 | lld:pubmed |